Nasal vaccination of six squirrel monkeys (Saimiri sciureus): Improved immunization protocol against Toxoplasma gondii with a nanoparticle-born vaccine

• Published in: International journal for parasitology. Parasites and wildlife 2023-12, Vol.22, p.69-74
• Main Authors: Fasquelle, François, Scuotto, Angelo, Vreulx, Anaïs-Camille, Petit, Thierry, Charpentier, Thomas, Betbeder, Didier
• Format: Article
• Language: English
• ISSN: 2213-2244; 2213-2244
• DOI: 10.1016/j.ijppaw.2023.09.002

Toxoplasma gondii is an intracellular protozoon found worldwide, which completes its life cycle between felids (its definitive host) and other warm-blooded animals. While the infection rarely leads to severe complications in humans, many animal species are very susceptible to this infection, for example the squirrel monkey (Saimiri sciureus) which is the subject of this study. Toxoplasmosis is lethal for 80% of cases in this species, and fatal outbreaks are frequently reported in zoological parks. No efficient treatment exists, but a new vaccine prepared with maltodextrin nanoparticles containing killed T. gondii antigens has been tested recently in French zoos. The animals were immunized through heterologous administrations, with two nasal doses at one-month interval, followed by nasal/subcutaneous boosts thereafter. No death has been reported since the beginning of this vaccination campaign, but we felt the protocol could be simplified. Here, an improved and less-invasive immunization protocol was evaluated on 6 Saimiri sciureus in the French zoo La Palmyre. It consisted of two nasal administrations at one-month interval, followed by a nasal boost at 6 months. A specific memory T-cell immunity was observed by ELISPOT after two administrations in all the animals, without humoral responses. The results suggest that 2 nasal administrations induce a protective immune response against T. gondii infection and might be sufficient to induce a strong Tcell memory, further improving immunity. [Display omitted] •Efficient nasal vaccine of Squirrel Monkeys against Toxoplasma gondii.•Nasal vaccination induces a specific T-cell immunity against Toxoplasma gondii.•Nanoparticle-born nasal vaccine against Toxoplasma gondii in zoo animals.